SUPERNUS PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
SUPERNUS PHARMACEUTICALS, INC. has filed 1,156 SEC EDGAR filings since 06 Mar 2006

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
4

4

Filing date
30 Mar 2016
Reporting date
29 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Mar 2016
Reporting date
16 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35518

8-K

Filing date
04 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35518

8-K

Filing date
03 Mar 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35518

8-K

Filing date
19 Feb 2016
Reporting date
18 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86843

ARDSLEY ADVISORY PARTNERS

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35518

8-K

Filing date
08 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86843

SC 13G filing

Filing date
28 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Dec 2015
Reporting date
28 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Dec 2015
Reporting date
08 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86843

SUPERNUS PHARMACEUTICALS #3

Filing date
10 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Dec 2015
Reporting date
04 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Dec 2015
Reporting date
03 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .